KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice.

Authors:
Sang-Hoon Sin
Sang-Hoon Sin
Dept. Microbiology & Immunology / University of North Carolina at Chapel Hill
Research Assistant Professor
KSHV
Chapel Hill, NC | United States

PLoS Pathog 2015 Sep 1;11(9):e1005135. Epub 2015 Sep 1.

Department of Microbiology and Immunology, Program in Global Oncology, Lineberger Comprehensive Cancer Center, and Center for AIDS Research, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Kaposi sarcoma-associated herpesvirus (KSHV) has been linked to Kaposi sarcoma and B-cell malignancies. Mechanisms of KSHV-induced oncogenesis remain elusive, however, in part due to lack of reliable in vivo models. Recently, we showed that transgenic mice expressing the KSHV latent genes, including all viral microRNAs, developed splenic B cell hyperplasia with 100% penetrance, but only a fraction converted to B cell lymphomas, suggesting that cooperative oncogenic events were missing. Myc was chosen as a possible candidate, because Myc is deregulated in many B cell lymphomas. We crossed KSHV latency locus transgenic (latency) mice to Cα Myc transgenic (Myc) mice. By itself these Myc transgenic mice develop lymphomas only rarely. In the double transgenic mice (Myc/latency) we observed plasmacytosis, severe extramedullary hematopoiesis in spleen and liver, and increased proliferation of splenocytes. Myc/latency mice developed frank lymphoma at a higher rate than single transgenic latency or Myc mice. These data indicate that the KSHV latency locus cooperates with the deregulated Myc pathways to further lymphoma progression.

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1005135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556645PMC
September 2015
10 Reads

Publication Analysis

Top Keywords

transgenic mice
12
latency locus
12
kshv latency
12
mice
8
cell lymphomas
8
transgenic latency
8
myc mice
8
myc transgenic
8
locus cooperates
8
myc
8
transgenic
6
kshv
5
splenocytes myc/latency
4
100% penetrance
4
hyperplasia 100%
4
proliferation splenocytes
4
genes including
4
extramedullary hematopoiesis
4
converted cell
4
fraction converted
4

References

(Supplied by CrossRef)
Reflecting on 25 years with MYC
N Meyer et al.
Nat Rev Cancer 2008
Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification
ES Jaffe et al.
Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program 2011
Burkitt Lymphoma in the Mouse
AL Kovalchuk et al.
The Journal of Experimental Medicine 2000
DRIVEN BY THE SAME IG ENHANCER AND SV40-T PROMOTER RAS INDUCED LUNG ADENOMATOUS TUMORS, MYC INDUCED PRE-B CELL LYMPHOMAS AND SV40 LARGE T-GENE A VARIETY OF TUMORS IN TRANSGENIC MICE
Y Suda et al.
EMBO Journal 1987

Similar Publications